Canada markets closed

Oryzon Genomics S.A. (ORYZF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
1.4100-0.7900 (-35.91%)
At close: 11:18AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 135.21M
Enterprise Value 136.79M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.99
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -16.30

Trading Information

Stock Price History

Beta (5Y Monthly) 0.60
52-Week Change 3-42.45%
S&P500 52-Week Change 323.49%
52 Week High 32.4500
52 Week Low 31.4100
50-Day Moving Average 31.6628
200-Day Moving Average 31.9324

Share Statistics

Avg Vol (3 month) 39
Avg Vol (10 day) 3N/A
Shares Outstanding 562.73M
Implied Shares Outstanding 695.9M
Float 850.79M
% Held by Insiders 115.69%
% Held by Institutions 10.76%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-3.17M
Diluted EPS (ttm)-0.0500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)1.31

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A